Seven months ago, Hospira executives were celebrating an FDA upgrade of a key manufacturing plant in North Carolina, a development they suggested was a sign that troubling quality-control issues at various facilities were starting to recede. And as Hospira chief executive Michael Ball told analysts in a conference callabout the agency move, “I think we’ve got the swamp drained” of alligators.
continue to read here
continue to read here
No comments:
Post a Comment